Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Cognitive Biomarkers in Pediatric Brain Tumor Patients

Study ID: NCT02914067
Start Date: 2016-10-26
End Date: 2028-01-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Neurocognitive testing

rsfcMRI

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Pancreatic Cancer Detection Consortium

Study ID: NCT06388967
Start Date: 2023-03-15
End Date: 2025-11-21
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment

PANcreatic cancer Exosome Early detectiON (PANXEON)

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer

Study ID: NCT04090567
Start Date: 2020-07-28
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Will cederanib

Ceralasertib

Flapberry

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

Study ID: NCT06305767
Start Date: 2024-03-28
End Date: 2031-10-20
Study Type

Interventional

Study Phase

Phase2

No. of Participants

230

Intervention / Treatment

Pembrolizumab

Intismeran autogene

Placebo

Emportumab Vedotin

Surgery (RC plus PLND)

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Time Restricted Eating (TRE) Among Endometrial Cancer Patients

Study ID: NCT04783467
Start Date: 2021-10-07
End Date: 2024-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

Time Restricted Eating (TRE) Schedule

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list

Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation

Study ID: NCT06798701
Start Date: 2025-06-15
End Date: 2026-01-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

28

Intervention / Treatment

Best Practice

Interview

Survey Administration

Virtual Reality

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

Study ID: NCT06623201
Start Date: 2024-10-07
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Aminolevuloullulinic Acid HCL (Ala)

BLU-U device model 4170E

Sponsor

Nathalie Zeitouni

Source: clinicaltrials.gov

Share:
Add to list

Adaptive Radiation for Abdominopelvic Metastases

Study ID: NCT05880667
Start Date: 2023-08-01
End Date: 2029-06-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Adaptive Stereotactic Body Radiation

Sponsor

Fox Chase Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Adaptive RADiation Therapy with Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

Study ID: NCT05833867
Start Date: 2024-04-01
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Sacituzumab Govitan

Adaptive Radiotherapy

Sponsor

Shilpa Gupta, MD

Source: clinicaltrials.gov

Share:
Add to list

A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Study ID: NCT05785767
Start Date: 2023-06-30
End Date: 2032-02-05
Study Type

Interventional

Study Phase

Phase3

No. of Participants

850

Intervention / Treatment

Familimab

Cemiplimab

Placebo

Sponsor

Regeneron Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list